A specialist in the treatment of cancers of the blood, bone marrow and lymph nodes, such as leukemia and lymphoma, Jakubowiak is best known for his work on the development and testing of new drugs for the treatment of multiple myeloma, a rare cancer that affects the white blood cells that make antibodies.